XML 64 R53.htm IDEA: XBRL DOCUMENT
v3.7.0.1

SEGMENT INFORMATION (Details) $ in Thousands | 3 Months Ended | 6 Months Ended |
--- | --- | --- | ---
Jun. 30, 2017 USD ($) | Jun. 30, 2016 USD ($) | Jun. 30, 2017 USD ($) Facility | Jun. 30, 2016 USD ($) | Dec. 31, 2016 USD ($)
SEGMENT INFORMATION [Abstract] |  |  |  |  |
Number of filling facilities | Facility |  |  | 2 |  |
Percentage decrease of chlorides released in environment |  |  | 75.00% |  |
Segment information [Abstract] |  |  |  |  |
Assets | $ 970,679 |  | $ 970,679 |  | $ 948,626
Depreciation/Amortization | 10,628 | $ 11,522 | 21,837 | $ 22,402 |
Capital expenditures |  |  | 10,819 | 14,736 |
Net sales | 147,082 | 138,794 | 284,810 | 273,935 |
Earnings before income taxes | 22,560 | 21,383 | 43,269 | 39,364 |
Transaction, integration costs, and legal settlement | (1,899) | (269) | (1,953) | (730) |
Indemnification settlement | 2,087 | 0 | 2,087 | 0 |
Interest and other income (expense) | (2,271) | (1,950) | (4,265) | (3,937) |
Human Nutrition & Health [Member] | Reportable Segments [Member] |  |  |  |  |
Segment information [Abstract] |  |  |  |  |
Assets | 726,293 |  | 726,293 |  | 709,337
Depreciation/Amortization | 8,196 | 8,513 | 16,311 | 16,594 |
Capital expenditures |  |  | 8,594 | 9,717 |
Net sales | 78,031 | 74,800 | 151,158 | 146,355 |
Earnings before income taxes | 11,320 | 9,024 | 21,516 | 17,396 |
Animal Nutrition & Health [Member] | Reportable Segments [Member] |  |  |  |  |
Segment information [Abstract] |  |  |  |  |
Assets | 113,562 |  | 113,562 |  | 121,860
Depreciation/Amortization | 1,145 | 1,872 | 3,034 | 3,678 |
Capital expenditures |  |  | 1,403 | 4,151 |
Net sales | 37,048 | 38,412 | 75,126 | 77,644 |
Earnings before income taxes | 3,689 | 7,304 | 9,065 | 13,839 |
Specialty Products [Member] | Reportable Segments [Member] |  |  |  |  |
Segment information [Abstract] |  |  |  |  |
Assets | 63,786 |  | 63,786 |  | 64,030
Depreciation/Amortization | 1,023 | 973 | 2,039 | 1,795 |
Capital expenditures |  |  | 411 | 565 |
Net sales | 20,759 | 20,325 | 39,549 | 37,442 |
Earnings before income taxes | 8,055 | 7,016 | 14,518 | 12,304 |
Industrial Products [Member] | Reportable Segments [Member] |  |  |  |  |
Segment information [Abstract] |  |  |  |  |
Assets | 14,263 |  | 14,263 |  | 10,477
Depreciation/Amortization | 264 | 164 | 453 | 335 |
Capital expenditures |  |  | 411 | 303 |
Net sales | 11,244 | 5,257 | 18,977 | 12,494 |
Earnings before income taxes | 1,579 | $ 258 | 2,301 | $ 492 |
Other Unallocated [Member] |  |  |  |  |
Segment information [Abstract] |  |  |  |  |
Assets | $ 52,775 |  | $ 52,775 |  | $ 42,922

X
- Definition Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, excluding amount unallocated to segments. + References No definition available. + Details
Name: | bcpc_DepreciationAndAmortizationExcludingAmountUnallocatedToSegments
Namespace Prefix: | bcpc_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Represents the number of filling facilities available for specialty products . + References No definition available. + Details
Name: | bcpc_NumberOfFillingFacilities
Namespace Prefix: | bcpc_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of amount of chlorides released into the environment reduced when compared to potassium chloride. + References No definition available. + Details
Name: | bcpc_PercentageDecreaseOfChloridesReleasedInEnvironment
Namespace Prefix: | bcpc_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(12)) -URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(11)) -URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878 + Details
Name: | us-gaap_Assets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The expenses and losses recorded for each transaction with the acquiree that was recognized separately from the acquisition of assets and assumptions of liabilities in the business combination. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e)(3) -URI http://asc.fasb.org/extlink&oid=65885119&loc=d3e1392-128463 + Details
Name: | us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)(1)(i)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 + Details
Name: | us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees. + References No definition available. + Details
Name: | us-gaap_LitigationSettlementExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.7) -URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688 + Details
Name: | us-gaap_NonoperatingIncomeExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3213-108585 + Details
Name: | us-gaap_PaymentsToAcquirePropertyPlantAndEquipment
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688 + Details
Name: | us-gaap_Revenues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingDisclosureOfOtherInformationAboutEntitysReportableSegmentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=bcpc_HumanNutritionHealthMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=bcpc_AnimalNutritionAndHealthMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=bcpc_SpecialtyProductsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=bcpc_IndustrialProductsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=us-gaap_MaterialReconcilingItemsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |